Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
12 July 2013
Header
Header image
Highlight of the week

News

IMI2 Launch to Further Innovative Medicines Initiative Success: Right Prevention and Treatment at the Right Time
10 July 2013

Brussels - July 10, 2013 - EFPIA and its specialised groups, Vaccines Europe and European Biopharmaceutical Enterprises, are pleased to announce the European Commission launch [...] Read more

News

News

IMI 9th call for proposals: Focus on Frailty, Use of social media to monitor drug safety, and Antibiotic Development
09 July 2013

BRUSSELS, 9 July 2013 – Today, the Innovative Medicines Initiative (IMI) is launching its 9th Call for proposals, with a total budget of €135 million [...] Read more

News

EFPIA Welcomes WHO Priority Medicines Report: Equitable Patient Access through Alignment of Public Health Needs and Innovation Incentives
12 July 2013

Brussels - July 12, 2013 – Following this Wednesday’s launch of IMI2, the follow-up to the first Innovative Medicines Initiative, EFPIA welcomes the publication of the [...] Read more

From our blog

From our blog

Speaking in Support of the Parliamentary Vote on Serious Cross-Border Threats to Health
08 July 2013 by Richard Bergström

I’ve noted before that the pharmaceutical industry ultimately exists to serve patients. This is something I’d like to clarify: It’s not just about the interests [...] Read more

From our blog

The Innovative Medicines Initiative: Beyond the 'Closed Club' of Innovation and Towards More Equitable Patient Access
12 July 2013 by Richard Bergström

If Europe wants to support innovation, it needs to also use that innovation. This is one of the topics touched on at yesterday’s IMI-2 launch, [...] Read more

Videos

Video

Launch of IMI 2

IMI Executive Director Michel Goldman and EFPIA Chair of Research Directors Group Peter Andersen discuss the launch of the Innovative Medicines Initative - 2.

View video

Video

EFPIA President Chris Viehbacher on the Innovative Medicines Initiative (IMI) .

EFPIA President Chris Viehbacher speaks on the Innovative Medicines Initiative (IMI) at the 2013 EFPIA Annual General Meeting Public Conference.

View video

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail